SERA PROGNOSTICS, INC. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
SERA PROGNOSTICS, INC. (SERA) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $42.05 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2026-08-12
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $42.05M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $43.21M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $35.17M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $39.15M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2026-06-30 | $42.05M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $43.21M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $35.17M 10-K · filed 2026-03-18 |
| 2025-09-30 | $39.15M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $35.11M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $40.89M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $42.10M 10-K · filed 2025-03-19 |
| 2024-09-30 | $46.93M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $46.41M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $48.88M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $45.38M 10-K · filed 2024-03-20 |
| 2023-09-30 | $36.78M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $31.86M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $43.91M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $53.39M 10-K · filed 2023-03-22 |
| 2022-09-30 | $50.76M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $53.71M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $43.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $46.21M 10-K · filed 2022-03-29 |
| 2021-09-30 | $37.51M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |